BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19628565)

  • 1. Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer.
    Donnem T; Al-Saad S; Al-Shibli K; Busund LT; Bremnes RM
    Ann Oncol; 2010 Feb; 21(2):223-231. PubMed ID: 19628565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
    Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
    J Thorac Oncol; 2009 May; 4(5):578-85. PubMed ID: 19318994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
    Donnem T; Al-Saad S; Al-Shibli K; Andersen S; Busund LT; Bremnes RM
    J Thorac Oncol; 2008 Sep; 3(9):963-70. PubMed ID: 18758297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-A and VEGFR-3 correlate with nodal status in operable non-small cell lung cancer: inverse correlation between expression in tumor and stromal cells.
    Donnem T; Al-Shibli K; Al-Saad S; Delghandi MP; Busund LT; Bremnes RM
    Lung Cancer; 2009 Feb; 63(2):277-83. PubMed ID: 18599153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
    Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
    Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of angiogenic markers in non-small-cell lung cancer is related to tumor size.
    Donnem T; Andersen S; Al-Saad S; Al-Shibli K; Busund LT; Bremnes RM
    Clin Lung Cancer; 2011 Mar; 12(2):106-15. PubMed ID: 21550557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of nestin in lymph node metastasis and lymphangiogenesis in non-small cell lung cancer patients.
    Chen Z; Wang T; Luo H; Lai Y; Yang X; Li F; Lei Y; Su C; Zhang X; Lahn BT; Xiang AP
    Hum Pathol; 2010 May; 41(5):737-44. PubMed ID: 20132963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of vascular endothelial growth factor (VEGF) C and VEGF receptor 3 in non-small cell lung cancer].
    Dong X; Qiu XS; Wang EH; Li QC; Gu W
    Zhonghua Bing Li Xue Za Zhi; 2003 Apr; 32(2):128-32. PubMed ID: 12839674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
    Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
    Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth factor-C and its association with lymphangiogenesis in primary human non-small cell lung cancer.
    Liu J; Liu C; Qiu L; Li J; Zhang P; Sun Y
    Diagn Pathol; 2014 Jun; 9():128. PubMed ID: 24972450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.
    Kilvaer TK; Valkov A; Sorbye SW; Smeland E; Bremnes RM; Busund LT; Donnem T
    J Transl Med; 2011 Jul; 9():104. PubMed ID: 21733164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis.
    Kitano H; Chung JY; Noh KH; Lee YH; Kim TW; Lee SH; Eo SH; Cho HJ; Choi CH; Inoue S; Hanaoka J; Fukuoka J; Hewitt SM
    J Transl Med; 2017 Jun; 15(1):138. PubMed ID: 28623914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
    Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
    Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density, and clinicopathologic characteristics in human non-small cell lung cancer.
    Guo X; Chen Y; Xu Z; Xu Z; Qian Y; Yu X
    Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):217-22. PubMed ID: 19280060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
    Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of VEGF-C and VEGFR-3 expression in non-small cell lung cancer.
    Li J; Hong M; Pan T
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):587-90. PubMed ID: 17219976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.
    Nordby Y; Richardsen E; Rakaee M; Ness N; Donnem T; Patel HR; Busund LT; Bremnes RM; Andersen S
    Sci Rep; 2017 Feb; 7():43378. PubMed ID: 28233816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.